Re:Doctors Slow to Adopt Tech Tools That Might Save Patients...
by DataDrivenMD on Saturday July 06, 2019 @12:39AM
(#20367907)
The most valuable asset a doctor has is the trust of their patients. Not going to risk that for a half-baked product with lukewarm support from its developer and a weak endorsement from NPR.
Even if this product could aggregate data from all the PBMs, that doesn't mean the drug will be in stock at a patient's local pharmacy.
Furthermore, there are many commonly prescribed drugs that are cheaper to buy outright using a discount program (not insurance). Also, there are manufacturer-to-patient rebates offered for some brand name drugs without a generic.
In short, there's a lot more information that doctors already factor into their decision-making process. This tool is not compelling enough to bring into the mix.
Even if this product could aggregate data from all the PBMs, that doesn't mean the drug will be in stock at a patient's local pharmacy.
Furthermore, there are many commonly prescribed drugs that are cheaper to buy outright using a discount program (not insurance). Also, there are manufacturer-to-patient rebates offered for some brand name drugs without a generic.
In short, there's a lot more information that doctors already factor into their decision-making process. This tool is not compelling enough to bring into the mix.